Parent Project Muscular Dystrophy announces partnership with Perky Jerky
Parent Project Muscular Dystrophy (PPMD), a nonprofit organization leading the fight to end Duchenne muscular dystrophy (Duchenne), is pleased to announce its partnership with Perky Jerky to sponsor select teams of PPMD's endurance fundraising program, Run For Our Sons.
Duchenne muscular dystrophy is the most common fatal genetic disorder diagnosed in childhood, affecting approximately one in every 5,000 boys. Run For Our Sons is PPMD's endurance fundraising program, which started in 2005 and has raised more than $10 million to help end Duchenne. Participants run in major marathons across the country to raise funds and awareness.
Perky Jerky is sponsoring Run For Our Sons teams at the following races:
- 2017 Disneyland Half Marathon Weekend presented by Cigna
- 2017 Bank of America Chicago Marathon
- 2017 TCS New York City Marathon
- 2018 Walt Disney World Marathon Weekend presented by Cigna
- 2018 Chevron Houston Marathon & Aramco Houston Half Marathon
"Duchenne muscular dystrophy is a disorder that is a part of my family's everyday life and that the Perky Jerky team is committed to combatting," said Brian Levin, CEO of Perky Jerky and parent of a child with Duchenne. "Organizations like PPMD are doing wonderful work to fund research that will benefit future generations, and I couldn't be more thankful for the work that they do. I have participated in several Run For Our Sons events and consider it an incredible program. We hope our contribution helps increase awareness of this terrible disease and ultimately leads to therapies that will end Duchenne."
"We are so grateful to Perky Jerky and the Levins for their support over the years, and we're thrilled to officially partner with them to bring more awareness to Duchenne," said Pat Furlong, founding president and CEO of PPMD. "This is a critical time for our community, with so many promising Duchenne treatments on the horizon, and we rely on the generosity of our corporate partners to help us maintain the momentum of our advocacy, education, care, and research efforts."